A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

Recruiting

Phase 1

INS1201A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

Sponsor:

Insmed Gene Therapy LLC

Code:

NCT06817382

Conditions

Duchenne Muscular Dystrophy

Eligibility Criteria

Sex: Male

Age: 2 - 4

Healthy Volunteers: Not accepted

Interventions

INS1201

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Insmed Gene Therapy LLC on 2025-04-11.